《中国糖尿病杂志》官方网站

20

您的位置:首页 > 中国糖尿病杂志 > 2013年 > 3期

地塞米松影响肝细胞糖代谢的机制及吡格列酮的干预作用的研究

来自:中国糖尿病杂志  编辑:王丹萍 邵明玮 宋素彩|点击数:|2013-04-02

  ·糖尿病基础研究·

  地塞米松影响肝细胞糖代谢的机制及吡格列酮的干预作用的研究

  王丹萍 邵明玮 宋素彩 汪丽娟 栗夏连

  【摘要】 目的 研究地塞米松在细胞水平对肝脏糖代谢和胰岛素的生物效应的影响,并观察吡格列酮(PGZ)在该过程中的干预作用。 方法 体外培养HepG2细胞,加入地塞米松作用不同的时间,GOD-POD法测上清葡萄糖浓度来确定影响细胞葡萄糖消耗量(GC)最明显的地塞米松作用时间,并观察PGZ在该条件下对细胞GC、糖原合成、糖异生及糖酵解过程的干预作用。 结果 1μmol/L地塞米松作用时间为36h时细胞GC下降最明显,作用时间48h时出现IR。PGZ组细胞糖原合成、糖异生指标较地塞米松组差异均有统计学意义(P<0.05),糖酵解指标差异无统计学意义(P>0.05),但在胰岛素存在时,PGZ和胰岛素在促进葡萄糖合成和酵解、抑制糖异生等糖代谢的各个环节均发挥协同作用(P<0.05)。 结论 地塞米松作用于肝细胞使其葡萄糖摄取能力及IS下降。PGZ通过糖代谢的多种途径发挥干预作用,其中主要通过糖原合成和糖异生,为临床上类固醇DM的治疗提供了分子基础。

  【关键词】 HepG2细胞;地塞米松;吡格列酮;糖代谢;过氧化物酶增殖体激活受体

  Mechanism of dexamethasone and intervention with pioglitazone on glucose metabolism in HepG2 cells WANG Dan-ping, SHAO Ming-wei, SONG Su-cai, et al. Department of Endocrinology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China

  Corresponding author: LI Xia-lian, E-mail: xialianli@hotmail.com

  【Abstract】 Objective To study the effect of dexamethasone on glucose metabolism and insulin sensitivity in HepG2 cells, and observe the intervention of pioglitazone on it . Methods Dexamethasone was added into the cultured HepG2 cells for different times, and the GOD-POD method was used to ascertain the best time of dexamethasone having the most obvious effect on glucose metabolism of HepG2 cells. Based on this, the intervention effect of pioglitazone through measuring the indicators of glucose consumption (GC), glycogen synthesis, gluconeogenesis, and glycolysis was observed as well. Results With the intervention of 1μmol/L dexamethasone for 36 hours, the decrease of GC of cells was the most significant, and insulin resistance (IR) occurred at 48 hours. The glycogen synthesis and gluconeogenesis of the PGZ group were significantly different from those of the dexamethasone group (P<0.05), while there was no statistical significant difference in indicators of glycolysis between the two groups (P>0.05). Insulin and pioglitazone had the co-effect on promoting glucose synthesis, glycolysis, and inhibiting gluconeogenesis when insulin was existed at the same time (P<0.05). Conlcusion Dexamethasone affects HepG2 cells, causing a decline of glucose intaking and IS. The action of PGZ on glucose metabolism is via glycogen synthesis and gluconeogenesis in a principal way. This conclusion provides more evidence for the clinical treatment of steroid diabetes.

  【Key Words】 HepG2 cells; Dexamethasone; Pioglitazone; Glucose metabolism; Peroxisome proliferator-activated receptor-γ

上一篇:磺脲类药物对成骨细胞MC3T3-E1自噬、凋亡和功能的影响 下一篇:克兰费尔特综合征合并糖尿病及骨质疏松1例